Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Having marker
Reexamination Certificate
1996-09-03
2002-01-01
Milano, Michael J. (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Having marker
Reexamination Certificate
active
06334871
ABSTRACT:
FIELD OF THE INVENTION
This invention relates to endoprosthesis devices, generally called stents, and, more particularly, to radiopaque markers for use with endoprosthesis devices.
BACKGROUND OF THE INVENTION
Stents are generally tubular shaped devices that function to hold open a segment of a blood vessel or other anatomical lumen and are useful in the treatment of atherosclerotic stenoses in blood vessels. Stents are particularly suitable for use in supporting and holding back a dissected arterial lining that can occlude the fluid passageway therethrough.
To accomplish precise placement of stents, various means are employed for identifying the position of the stent within a blood vessel. One means used for accomplishing precise placement of a stent is the attachment to the stent of radiopaque markers so that, through the use of fluoroscopy, the position of the stent within a blood vessel can be identified. Once the stent with its radiopaque markers has been implanted, identification of the stent position during subsequent checkups of the treated segment is easily accomplished because the markers remain visible under fluoroscopy.
In European patent application No. 95302708, assigned to ACS, Inc., a method of coating the stent edges as markers is described. However, this method has several practical disadvantages. First, heavy coating of radiopaque markers onto a stent is somewhat difficult to accomplish. In addition, the radiopaque material might not be attached properly to the stent material and may detach, leaving no way of identifying the position of the stent within the blood vessel. Furthermore, the radiopaque coating may increase the rigidity of the stent, thereby making it difficult to open the stent and decreasing the stent's effectiveness.
In another method for enabling the precise identification of a stent location using radiopaque markers, commonly assigned U.S. patent application Ser. No. 08/394,799, filed Feb. 27, 1995, discloses a hollow stent having radiopaque material inserted within the hollow stent wire. Because this method of providing radiopaque marking requires that the stent wire is hollow, this method might not be useful where a hollow stent is not desirable.
Another well-known method for enabling the precise identification of a stent location within a blood vessel is producing the stent itself from a radiopaque material such as tantalum. However, a disadvantage of this method is that tantalum is a relatively soft material and it is, therefore, necessary to use more of this metal to achieve sufficient support from the stent.
OBJECTS OF THE INVENTION
It is an object of the invention to provide improved stents.
It is also an object of the invention to provide stents having radiopaque markers.
It is a further object of the invention to provide stents where the distal ends of the stents comprise rivets of material that is more radiopaque than the material from which the stents are made.
These and other objects of the invention will become more apparent in the discussion below.
SUMMARY OF THE INVENTION
The radiopaque markers described below are designed for stents produced from a material that is not sufficiently radiopaque to be seen through the use of fluoroscopy, e.g., a material such as Stainless Steel 316L, nitinol, or a cobalt-chromium alloy. In order to identify the position of the stent during its insertion into the body and after it has been implanted, however, it is enough to mark the stent edges so that they may be seen under X-ray. The location of the stent will thus be evident based upon the pinpoint locations of its two ends.
According to this invention the edges of the stents are marked by inserting rivets through the ends or edges of the stents, which rivets are made of a material that is more radiopaque than the stent material. For example, if the stent material is S.S. 316L, the rivets can be made of gold, gold alloy, tantalum, tantalum alloy, platinum, or platinum alloy.
REFERENCES:
patent: 264502 (1882-09-01), Woolson
patent: 3902501 (1975-09-01), Citron et al.
patent: 4051592 (1977-10-01), Briles
patent: 4531243 (1985-07-01), Weber
patent: 4733665 (1988-03-01), Palmaz
patent: 4828566 (1989-05-01), Griss
patent: 5080674 (1992-01-01), Jacobs
patent: 5104404 (1992-04-01), Wolff
patent: 5306250 (1994-04-01), March
patent: 5366473 (1994-11-01), Winston
patent: 5443520 (1995-08-01), Zweymüller
patent: 5556413 (1996-09-01), Lam
patent: 5607442 (1997-03-01), Fischell et al.
patent: 5632771 (1997-05-01), Boatman et al.
patent: 5725570 (1998-03-01), Heath
patent: 5725572 (1998-03-01), Lam et al.
patent: 5800508 (1998-09-01), Goicoechea et al.
patent: 5824042 (1998-10-01), Lombardi et al.
patent: 5824077 (1998-10-01), Mayer
patent: 6066168 (2000-05-01), Lau et al.
patent: 6203569 (2001-03-01), Wijay
patent: 0 679 372 (1995-11-01), None
patent: 1205743 (1970-09-01), None
patent: WO 95/03010 (1995-02-01), None
Beyar Mordechay
Beyar Rafael
Dor Ofer
Globerman Oren
Loshakove Amir
Medtronic Inc.
Milano Michael J.
Mueting Raasch & Gebhardt, P.A.
LandOfFree
Radiopaque stent markers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiopaque stent markers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiopaque stent markers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2864974